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General.
1 H, 13 C and 31 P NMR spectra were recorded on a Bruker DRX 300 MHz or Avance II+ 600 MHz instrument. The chemical shifts are referenced to the residual proton signal of the deuterated solvents: CDCl 3 (7.26 ppm), d 6 -DMSO (2.49 ppm) for 1 H NMR spectra; CDCl 3 (77.0 ppm) or d 6 -DMSO (39.5 ppm) for 13 C NMR spectra. 31 P-shifts are relative to external 85% phosphoric acid. 1 H-and 13 C-assignments were based on COSY and HSQC experiments. MS experiments were performed on a Finnigan LCQ Advantage MAX ion trap instrument. Analytical thin-layer chromatography (TLC) was carried out on Marchery-Nagel Polygram SIL G/UV254 plates. Flash column chromatography was carried out on silica gel 60 (70-230 mesh). All reactions were carried out under argon atmosphere. Chemical reagents and solvents were purchased from commercial suppliers and used without further purification. Organic solvents for reactions were dried overnight over freshly activated molecular sieves (4 Å). 
3'-O-(tert-butyldimethylsilyl)-5'-O-(4,4-dimethoxytrityl)-2'-deoxy-2'-trifluoromethylthiouridine (C2
3'-O-(tert-butyldimethylsilyl)-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-trifluoromethylthiocytidine (C4).
The crude compound C3 (143 mg, 0.14 mmol) which was dried under vacuum, was dissolved in THF (2.9 ml) and treated with aqueous ammonia (4.3 ml, 32%). The solution was stirred at room temperature overnight. The solvents were evaporated, the mixture was diluted with dichloromethane, extracted with water, dried over 
-Acetyl-3'-O-(tert-butyldimethylsilyl)-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2' trifluoromethylthiocytidine (C5).
A solution of C4 (450 g, 0.60 mmol) in dry pyridine (1.1 ml) was cooled to 0°C under argon, treated with acetic anhydride (145 µl, 1.53 mmol), allowed to warm to room temperature and stirred for 90 minutes. The reaction was quenched by the addition of methanol (0.2 ml) and the solvents were evaporated. The oily residue was diluted with dichloromethane, extracted with 5% citric acid, water and saturated sodium bicarbonate solution, dried over Na 2 SO 4 and evaporated. 
N
-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-trifluoromethylthiocytidine-3'-O-(2-cyanoethyl N,Ndiisopropylphosphoramidite) (C7).
Compound C6 (366 mg, 0.55 mmol) was dissolved in dry dichloromethane (1.5 mL) and treated with ethyldimethylamine (588 µl, 5.43 mmol) at room temperature under argon atmosphere.
After 25 min 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (194 mg, 0.82 mmol) was slowly added to the solution and stirring was continued for 2.5 hours. The reaction was quenched by the addition of methanol (1 ml), diluted with dichlormetane and extracted with saturated sodium bicarbonate solution. Organic layer was dried over Na 2 SO 4 and evaporated. UV-detection at 254 nm.
Isothermal titration calorimetry. ITC measurements were performed on a MicroCal ITC200 (GE Healthcare), in buffer containing 10 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.0. ITC data were analyzed using the dedicated software by Microcal (Origin 7.0). All data were fitted with a one-sites model. 
